Results 171 to 180 of about 383,545 (266)

Squamous Cell Carcinoma of the Skin in a Teenager with Fanconi Anemia: A Challenging Treatment. [PDF]

Int J Mol Sci
Zelenova E, Belysheva T, Orlova K, Grigorenko V, Semenova V, Sharapova E, Vishnevskaya Y, Samoylenko I, Nasedkina T, Valiev T, Polyakov V, Varfolomeeva S.   +11 more
europepmc   +1 more source

Biomarkers in oral squamous cell carcinoma: a systematic review. [PDF]

Med Oral Patol Oral Cir Bucal
López-Galindo M, Sousa-Roques MD.
europepmc   +1 more source

Early and High‐Dose Glucocorticoid Use and Survival in Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Multicenter Target Trial Emulation

Clinical Pharmacology &Therapeutics, EarlyView.
Despite the immunomodulatory mechanism of immune checkpoint inhibitors (ICIs), systemic glucocorticoids are commonly used in advanced non–small cell lung cancer (NSCLC). Evidence regarding their effects on ICI outcomes is inconsistent, in part due to confounding by indication and immortal time bias.
Da Eun Lee, Geunho Lim, Minoh Ko, Mari Kim, Ji Sun Chun, Borim Lee, Miso Kim, Kwangsoo Kim, Byung Kwan Choi, Jeongmin Seo, Jin Hyoung Kang, Taehoon Ko, In‐Wha Kim, Jung Mi Oh   +13 more
wiley   +1 more source

Identification of protein lysine lactylation and potential targets in esophageal squamous cell carcinoma. [PDF]

Transl Cancer Res
Zhang H, Yan X, Xi L, Chen S, Shang Q, Chen LQ, Wang WP.   +6 more
europepmc   +1 more source

Population Pharmacokinetics and Exposure‐Response Analyses to Support Cofetuzumab Pelidotin (ABBV‐647) Dose Optimization in Non‐Small Cell Lung Cancer Patients

Clinical Pharmacology &Therapeutics, EarlyView.
Cofetuzumab pelidotin (Cofe‐P) is an anti‐protein tyrosine kinase 7 (PTK7) antibody‐drug conjugate (ADC) being investigated for the treatment of adults with PTK7‐expressing, recurrent non‐small cell lung cancer (NSCLC). The first‐in‐human (FIH) trial demonstrated tolerability of dosages ≤ 2.8 mg/kg once every 3 weeks (Q3W) and ≤ 3.2 mg/kg Q2W ...
Carla Biesdorf, Melanie Rinas, Benjamin Engelhardt, Rabih Saab, Cen Guo, Cristiano Ferlini, Kevin J. Freise, Rajeev M. Menon, Akshanth R. Polepally   +8 more
wiley   +1 more source

Evolving Principles for Oral Squamous Cell Carcinoma Screening Programs. [PDF]

Cancers (Basel)
Santos-Silva AR, Epstein JB, Kowalski LP, Esteves-Pereira TC, Prado-Ribeiro AC, Martins MD, Lopes MA, Sollecito TP.   +7 more
europepmc   +1 more source

Challenges and Pitfalls to Diagnosing NUTM1‐Rearranged Neoplasia of the Pancreas by Cytology and Ancillary Studies

Diagnostic Cytopathology, EarlyView.
ABSTRACT Fine‐needle aspiration cytology specimens are frequently utilized for ancillary studies to identify diagnostic and prognostic information. This case highlights diagnostic pitfalls and challenges in diagnosing NUTM1‐rearranged neoplasia on pancreatic cytology.
Terrance J. Lynn
wiley   +1 more source

Correction: Investigating the oncogenic potential of MTHFD2 in oral squamous cell carcinoma. [PDF]

J Cancer Res Clin Oncol
Han J, Wang W, Li S, Wang J.
europepmc   +1 more source

Extended High‐Risk HPV Genotyping With BD Onclarity Enhances Anal Cancer Screening Among High‐Risk Populations: A Cross‐Sectional Study

Diagnostic Cytopathology, EarlyView.
ABSTRACT Background Anal cancer rates are rising among women, immunocompromised individuals, and Men who have sex with Men (MSM), independent of HIV status. While high‐resolution anoscopy remains the diagnostic standard, limited access has increased interest in alternative screening.
Daisy Maharjan, Joshua Waters, Melissa Randolph, Benjamin Shuler, Julie Borum, Sheila Segura   +5 more
wiley   +1 more source